Figure1 (Tramadol Fig1)
Tramadol Hydrochloride Tablet, Film Coated
Product Images NDC 59651-441
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 59651-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Clinical Studies Section (Tramadol Fig2)
This seems to be a graph or chart showing the percentage of participants who discontinued a protocol (CAPSS-047) due to nausea/vomiting at specific times during the study. The X-axis shows the days in a double-blind period, and there appears to be a line showing time to discontinuation due to nausea/vomiting at a dosage of 200 mg/day. However, without context, it is difficult to provide a more specific description or interpretation of the data.*
Tramadol-fig3 (Tramadol Fig3)
This is a description of a medication named Tramadol Hydrochloride USP. The package is made in India and distributed by Aurobindo Pharma USA, Inc. The tablet's usual dosage and prescribing information is included in the accompanying package insert with a code of AP/DRUGS/04/2016. The tablets should be stored at a temperature range of 20° to 25°C (68° to 77°F) in a tight container. The medication guide is provided separately to each patient by the pharmacist. The packaging includes the NDC and other information including manufacturing details and precautions, like "keep out of the reach of children."*
Structure (Tramadol Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
